1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Gnomestar Craft Inc.

Gnomestar Craft Inc.

VDQSF
Gnomestar Craft Inc.US flagOther OTC
0.01
USD
+0.01
- -
5.25MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.23
-0.06
-0.1
-0.25
-0.15
-0.27
-0.12
-0.09
-0.02
-0.01
-0.01
Free Cash Flow per Basic Share
-0.18
-0.09
-0.04
-0.12
-0.1
-0.04
-0.09
-0.03
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.23
-0.12
-0.18
-0.26
-0.28
-0.07
-0.08
-0.09
-0.07
-0.06
-0.06
Tangible Book Value per Share
0.51
0.09
0.27
0.03
0.02
0.04
0.02
-0.02
-0.02
-0.02
-0.02
Basic Weighted Avg Shares
- -
1
2
10
17
23
32
48
65
80
85
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
-2,736.96
-31,802.54
- -
- -
- -
-370.36
-709.4
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
Net Income, GAAP
- -
- -
- -
-2
-2
-6
-4
-4
-1
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-3,000.71
-59,749.21
- -
- -
- -
-328.54
-493.89
Working Capital
- -
- -
1
- -
-1
-1
-1
-2
-2
-2
-2
LT Debt
- -
- -
- -
- -
2
2
2
- -
- -
1
- -
Total Equity
- -
- -
1
- -
- -
1
1
-1
-1
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
85
85
85
Market Capitalization
4
2
1

Working Capital

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
3
3
Payables & Accruals
2
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-14.25%
16.8%
Free Cash Flow
- -
1.16%
-43.71%
Net Income, GAAP
- -
4.1%
-32.79%
Sales/Revenue/Turnover
- -
- -
2,473.91%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
-0.01
- -
- -
-0.02
2021
- -
- -
- -
- -
-0.01
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Mark Lotz BBA, CA,
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
8788 River Road Delta BC Canada V4G 1B5
IPO Date
Feb 13, 2015
Website
gnomestarcannabis.com
Similar Companies
Dong-E-E-Jiao Co.,Ltd. (000423.SZ)
Halo Collective Inc. (HCANF)
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK)
Siegfried Holding AG (SFZN.SW)
4Cable TV International, Inc. (CATV)
Business
Gnomestar Craft Inc. (VDQSF) is a Canada-based craft cannabis company that produces and sells dried flower and derivative products for medical and recreational use through its licensed 12,000 square foot indoor facility in Delta, British Columbia; the company specializes in hand-harvested, hang-dried, and hand-trimmed proprietary cultivars such as the high-THC Meat Breath hybrid strain with over 23.8% THC and 2.7% terpenes, targeting premium consumers in the adult-use market with an annual capacity of approximately 1,500 kilograms. Founded in 2014 as Vodis Pharmaceuticals Inc. and renamed Gnomestar Craft Inc. in conjunction with its rebranding to premium craft cannabis production under the Gnomestar label, the company operates primarily in Canada with distribution partnerships including a 2020 processing and supply agreement with BC Craft Supply Co. Ltd. for sales to Indiva Ltd.'s Artisan Batch brand and a master processing agreement with Indiva for packaging into 3.5-gram jars. In February 2022, Gnomestar appointed Jordan Nott, a fundraising and property development expert, to its board of directors to support growth initiatives amid ongoing facility upgrades and product development focused on concentrates and extracts; the company trades on the Canadian Securities Exchange (CSE:GNOM) but faced a late filing of annual financial statements leading to a management cease trade order, with shares also listed OTC (VDQSF). Headquartered at 8788 River Road in Delta, British Columbia, Gnomestar maintains standard cultivation and processing licenses under the Cannabis Act, positioning it within the competitive Canadian cannabis sector emphasizing small-batch quality over mass production.